Rankings
▼
Calendar
VTRS FY 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
FY 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$11.4B
-4.0% YoY
Gross Profit
$4.0B
35.0% margin
Operating Income
$906M
7.9% margin
Net Income
$353M
3.1% margin
EPS (Diluted)
$0.68
Cash Flow
Operating Cash Flow
$2.3B
Free Cash Flow
$2.1B
Stock-Based Comp.
-$71M
Balance Sheet
Total Assets
$32.7B
Total Liabilities
$20.6B
Stockholders' Equity
$12.2B
Cash & Equivalents
$388M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11.4B
$11.9B
-4.0%
Gross Profit
$4.0B
$4.8B
-16.3%
Operating Income
$906M
$1.4B
-37.0%
Net Income
$353M
$696M
-49.4%
← Q4 2017
All Quarters
Q1 2018 →